Therapeutic areas
Our therapeutic areas reflect EleaExeltis regional approach to developing solutions for complex diseases. We work in highly specialized fields, supporting healthcare professionals and contributing to regional access to innovative, effective, and high-quality therapies.
HIV
HIV is a chronic condition that continues to represent a significant challenge for healthcare systems across the region. At EleaExeltis, we specialize in the development and provision of therapies for the treatment of HIV, supporting healthcare professionals in different countries and contributing to improving patients’ life expectancy and quality of life at a regional level.
Hematology
Hematology encompasses complex diseases affecting the blood and the organs responsible for its production, with a significant impact across the region. At EleaExeltis, we work on therapeutic solutions for hematological conditions that require a high level of specialization, providing options aimed at strengthening clinical management across the different markets where we operate.
Rare Diseases
Rare diseases are characterized by their low prevalence, high complexity, and significant impact on patients’ lives, particularly in settings where access to specialized treatments is limited. At EleaExeltis, we focus our efforts on the development and availability of therapies for these conditions, supporting medical teams across the region in the management of diseases that require specific and sustained solutions.
Oncology
Cancer treatment poses increasingly complex clinical challenges for healthcare systems across the region. At EleaExeltis, we develop and offer oncology therapies aimed at different tumor types, with the goal of contributing to regional access to treatments aligned with scientific advances and modern oncology medicine.
Onco-Hematology
Onco-hematology addresses blood cancers such as leukemias, lymphomas, and myelomas—conditions of high clinical complexity within the regional context. At EleaExeltis, we integrate our expertise in oncology and hematology to provide therapeutic solutions focused on these diseases, supporting healthcare professionals across different countries through a specialized and regional approach.